Stock MSSV MESO NUMISMATICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Meso Numismatics, Inc.

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 03:40:26 2024-05-16 pm EDT 		5-day change 1st Jan Change
0.036 USD -3.81% Intraday chart for Meso Numismatics, Inc. 0.00% +393.15%
Apr. 15 Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 04 Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc CI

Business Summary

Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.

Number of employees: 1

Sales per Business

USD in Million2022Weight2023Weight Delta
Product Supplies
55.2 %
1 56.6 % 1 55.2 % +53.46%
Training
24.9 %
0 18.3 % 1 24.9 % +114.54%
Patient Procedures
13.2 %
0 14.5 % 0 13.2 % +44.18%
Equipment
6.7 %
0 10.7 % 0 6.7 % -0.67%

Sales per region

USD in Million2022Weight2023Weight Delta
Latin America
100.0 %
2 100.0 % 2 100.0 % +57.49%

Managers

Managers TitleAgeSince
David Christensen CEO
 Chief Executive Officer 59 19-11-26

Members of the board

Members of the board TitleAgeSince
David Christensen CEO
 Chief Executive Officer 59 19-11-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 9,870 0 0 84.19 %
Stock B 1 12,493,938 11,411,461 ( 91.34 %) 0
Stock C 0 1,050,000 0 0

Shareholders

NameEquities%Valuation
Ajene Watson LLC
8.664 %
1,082,477 8.664 % 51 959 $
NameEquities%Valuation
Benito Novas
95.24 %
1,000,000 95.24 % 48 000 $
David Christensen
4.762 %
50,000 4.762 % 2 400 $

Company contact information

Meso Numismatics, Inc.

433 Plaza Real Suite 275

33432, Boca Raton

+

address Meso Numismatics, Inc.(MSSV)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MESO NUMISMATICS, INC. Stock Meso Numismatics, Inc.
+393.15% 450K
MODERNA, INC. Stock Moderna, Inc.
+32.09% 50.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.89% 42.82B
LONZA GROUP AG Stock Lonza Group AG
+48.94% 42.03B
CELLTRION, INC. Stock Celltrion, Inc.
-4.22% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.95% 26.11B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.72% 19.13B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.20% 13.05B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.74% 12.16B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+23.33% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MSSV Stock
  4. Company Meso Numismatics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW